Header Logo

Kevin High

Concepts (452)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aging
25
2019
934
3.980
Why?
Geriatrics
11
2019
112
2.660
Why?
Geriatric Assessment
7
2019
361
1.600
Why?
Communicable Diseases
5
2009
19
1.500
Why?
HIV Infections
5
2015
247
1.310
Why?
Aged
41
2019
9941
1.200
Why?
Humans
69
2019
28820
1.030
Why?
Community-Acquired Infections
5
2005
31
1.000
Why?
Air Ambulances
2
2016
9
0.980
Why?
Biomedical Research
7
2017
164
0.880
Why?
Herpes Zoster
3
2009
11
0.840
Why?
Interleukin-23
4
2014
13
0.820
Why?
Respiratory Tract Infections
4
2012
39
0.820
Why?
Dendritic Cells
2
2010
62
0.810
Why?
Fever of Unknown Origin
2
2009
9
0.800
Why?
Patient Care Planning
1
2019
50
0.770
Why?
Frail Elderly
4
2019
62
0.760
Why?
Kidney Diseases
4
2014
242
0.750
Why?
Vaccination
2
2010
93
0.740
Why?
Disability Evaluation
1
2019
224
0.730
Why?
JC Virus
2
2014
25
0.700
Why?
Polyomavirus Infections
2
2014
22
0.700
Why?
Tumor Virus Infections
2
2014
22
0.700
Why?
Activities of Daily Living
4
2009
238
0.690
Why?
Apolipoproteins
3
2014
220
0.690
Why?
Pneumonia, Bacterial
3
2005
29
0.670
Why?
Lipoproteins, HDL
3
2014
270
0.670
Why?
Thoracostomy
1
2016
5
0.670
Why?
Pneumothorax
1
2016
9
0.670
Why?
Research
4
2010
80
0.640
Why?
Internal Medicine
4
2006
48
0.640
Why?
Transcription Factors
2
2009
183
0.600
Why?
Comorbidity
8
2015
554
0.590
Why?
Pneumonia
2
2005
61
0.590
Why?
Inflammation
2
2012
511
0.580
Why?
Aging, Premature
1
2013
3
0.560
Why?
Anti-Infective Agents
3
2015
43
0.550
Why?
Cytokines
2
2012
235
0.550
Why?
Physical Fitness
2
2012
120
0.540
Why?
T-Lymphocytes
3
2013
116
0.540
Why?
Wounds and Injuries
1
2016
245
0.530
Why?
Female
28
2019
18715
0.530
Why?
Chronic Disease
6
2016
387
0.520
Why?
United States
14
2017
3708
0.520
Why?
Aged, 80 and over
12
2019
3878
0.520
Why?
Bacterial Translocation
1
2012
8
0.520
Why?
Acute-Phase Proteins
1
2012
10
0.520
Why?
Diabetes Complications
1
2014
203
0.510
Why?
Male
26
2019
18406
0.510
Why?
Membrane Glycoproteins
2
2012
99
0.510
Why?
Models, Immunological
1
2012
10
0.510
Why?
Panax
1
2012
4
0.500
Why?
Middle Aged
17
2016
11394
0.490
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2012
21
0.490
Why?
Virus Diseases
2
2012
13
0.490
Why?
Health Services Research
1
2012
71
0.480
Why?
Medicine
4
2017
35
0.480
Why?
Carrier Proteins
1
2012
112
0.480
Why?
B-Lymphocytes
3
2010
69
0.470
Why?
Plant Extracts
1
2012
61
0.460
Why?
Models, Biological
1
2013
372
0.460
Why?
Idiopathic Pulmonary Fibrosis
1
2010
8
0.450
Why?
Health Priorities
1
2010
14
0.450
Why?
Clostridium difficile
3
2016
12
0.440
Why?
Dinoprostone
1
2010
32
0.440
Why?
Evidence-Based Practice
1
2010
18
0.430
Why?
Interleukin-12
3
2014
26
0.420
Why?
Transportation of Patients
2
2009
14
0.420
Why?
Adult
15
2016
8605
0.410
Why?
Herpes Zoster Vaccine
1
2009
4
0.410
Why?
Acute Disease
2
2012
237
0.410
Why?
Interleukin-23 Subunit p19
1
2009
12
0.410
Why?
Homes for the Aged
1
2009
11
0.400
Why?
Histones
1
2009
47
0.400
Why?
Patient Care Management
1
2009
17
0.400
Why?
Nursing Homes
1
2009
30
0.400
Why?
Antibodies, Bacterial
2
2013
34
0.390
Why?
Cross Infection
1
2009
45
0.390
Why?
African Americans
2
2014
1631
0.380
Why?
Cytomegalovirus Infections
4
2013
22
0.380
Why?
Risk Factors
10
2016
3660
0.370
Why?
Herpesvirus Vaccines
1
2007
1
0.370
Why?
Herpesvirus 3, Human
1
2007
3
0.370
Why?
Brucella abortus
1
2007
2
0.360
Why?
Brucellosis
1
2007
5
0.360
Why?
Viral Vaccines
1
2007
12
0.360
Why?
Home Infusion Therapy
1
2007
1
0.360
Why?
Home Care Services, Hospital-Based
1
2007
2
0.360
Why?
Immunization
1
2007
26
0.360
Why?
Patient Acceptance of Health Care
1
2009
162
0.350
Why?
Neuralgia
1
2007
47
0.350
Why?
Animals
13
2015
7492
0.340
Why?
Congresses as Topic
4
2019
44
0.340
Why?
Health Services Accessibility
1
2009
233
0.340
Why?
Cardiovascular Diseases
2
2014
1092
0.340
Why?
Specialization
3
2019
37
0.330
Why?
Hematopoietic Stem Cell Transplantation
2
2007
88
0.330
Why?
Gene Expression Regulation
1
2009
485
0.320
Why?
Antigens, Surface
1
2005
19
0.320
Why?
Individuality
1
2005
6
0.320
Why?
Apoptosis
4
2006
364
0.310
Why?
Hospitals, University
1
2005
25
0.310
Why?
Mice
7
2015
2316
0.310
Why?
Spleen
1
2005
84
0.310
Why?
Skin Ulcer
2
2015
13
0.310
Why?
Clostridium Infections
2
2016
8
0.310
Why?
Malnutrition
1
2005
11
0.310
Why?
Immunologic Factors
1
2005
51
0.310
Why?
Prognosis
6
2013
1394
0.300
Why?
Trauma Centers
1
2005
81
0.300
Why?
Influenza Vaccines
3
2014
73
0.300
Why?
Long-Term Care
4
2014
19
0.290
Why?
Health Status Indicators
1
2004
76
0.290
Why?
Prostaglandin D2
2
2005
4
0.280
Why?
Postural Balance
1
2016
127
0.280
Why?
Hepatitis C, Chronic
2
2015
80
0.280
Why?
Anti-Bacterial Agents
3
2013
286
0.270
Why?
Cognition
2
2005
537
0.270
Why?
alpha-Tocopherol
1
2002
3
0.260
Why?
Vitamin A
1
2002
9
0.260
Why?
Receptors, Cytoplasmic and Nuclear
1
2002
15
0.260
Why?
Awards and Prizes
1
2002
10
0.260
Why?
Mucous Membrane
1
2002
22
0.260
Why?
Pesticides
1
2016
238
0.250
Why?
Incidence
4
2012
1141
0.250
Why?
Hematologic Neoplasms
1
2002
28
0.250
Why?
Occupational Exposure
1
2016
287
0.250
Why?
Emigrants and Immigrants
1
2016
274
0.240
Why?
Transients and Migrants
1
2016
379
0.240
Why?
Academic Medical Centers
1
2002
151
0.230
Why?
Health Services Needs and Demand
2
2012
60
0.220
Why?
Young Adult
4
2016
2402
0.220
Why?
Intubation, Intratracheal
2
2019
64
0.220
Why?
Stem Cell Transplantation
1
2002
207
0.220
Why?
Age Factors
6
2015
1179
0.220
Why?
Education, Medical
2
2019
77
0.220
Why?
Evidence-Based Medicine
2
2014
193
0.210
Why?
Attitude of Health Personnel
1
2002
168
0.210
Why?
Staff Development
1
2019
14
0.210
Why?
Linear Models
4
2015
453
0.210
Why?
Treatment Outcome
6
2016
3132
0.210
Why?
Continuous Positive Airway Pressure
1
2019
7
0.210
Why?
Mice, Inbred C57BL
3
2013
691
0.200
Why?
Teaching
1
2019
54
0.200
Why?
Mentors
1
2019
31
0.200
Why?
Up-Regulation
2
2010
200
0.200
Why?
Leadership
1
2019
34
0.200
Why?
Physical Therapy Modalities
1
2019
72
0.200
Why?
Faculty, Medical
1
2019
75
0.200
Why?
Age Distribution
3
2013
208
0.200
Why?
Breast Neoplasms
2
2002
718
0.200
Why?
Immunity, Innate
2
2016
60
0.190
Why?
Hispanic Americans
1
2016
1119
0.180
Why?
PPAR gamma
2
2015
42
0.180
Why?
Adolescent
4
2016
3176
0.180
Why?
Mobility Limitation
1
2019
189
0.180
Why?
Safety
2
2009
89
0.180
Why?
Career Mobility
1
2017
18
0.170
Why?
Acquired Immunodeficiency Syndrome
1
2016
12
0.170
Why?
Mice, Inbred DBA
2
2007
35
0.170
Why?
Wound Healing
2
2015
174
0.170
Why?
Empyema
1
2016
2
0.170
Why?
Chest Tubes
1
2016
6
0.170
Why?
Severity of Illness Index
4
2015
898
0.170
Why?
Cardiopulmonary Resuscitation
1
2016
24
0.160
Why?
Kidney Failure, Chronic
2
2012
550
0.160
Why?
Arachidonic Acid
2
2006
36
0.160
Why?
Lymphocyte Count
2
2005
25
0.160
Why?
PPAR alpha
1
2015
14
0.160
Why?
Cell Survival
4
2010
280
0.160
Why?
Morbidity
2
2007
95
0.160
Why?
Surgical Wound Infection
1
2016
66
0.160
Why?
Forecasting
3
2015
139
0.160
Why?
Mice, Inbred BALB C
3
2014
151
0.160
Why?
Aviation
1
2015
1
0.150
Why?
Electric Stimulation Therapy
1
2015
22
0.150
Why?
CD8-Positive T-Lymphocytes
2
2005
83
0.150
Why?
Retrospective Studies
4
2016
2921
0.150
Why?
Negative-Pressure Wound Therapy
1
2015
45
0.140
Why?
Adaptive Immunity
2
2013
13
0.140
Why?
Digestive System
1
2013
3
0.140
Why?
Influenzavirus A
1
2013
1
0.140
Why?
Population Groups
1
2013
9
0.140
Why?
Virion
1
2013
7
0.140
Why?
Patient Care
1
2014
28
0.140
Why?
Hyperglycemia
1
2014
86
0.140
Why?
Mass Vaccination
1
2013
7
0.140
Why?
Adjuvants, Immunologic
1
2014
52
0.140
Why?
Central Nervous System Neoplasms
1
2014
30
0.140
Why?
Double-Blind Method
2
2013
533
0.140
Why?
Eye
1
2013
19
0.140
Why?
Pneumonia, Pneumococcal
1
2013
14
0.140
Why?
RNA, Messenger
1
2015
534
0.140
Why?
Societies, Medical
3
2017
142
0.140
Why?
Multivariate Analysis
2
2012
700
0.140
Why?
B-Lymphocyte Subsets
1
2013
18
0.130
Why?
Pneumococcal Vaccines
1
2013
33
0.130
Why?
Hepatitis B Vaccines
1
2013
9
0.130
Why?
Enterocolitis, Pseudomembranous
1
2013
7
0.130
Why?
Hepatitis B
1
2013
15
0.130
Why?
Bile Duct Diseases
1
2013
8
0.130
Why?
Diabetes Mellitus
1
2016
425
0.130
Why?
Gene Expression Regulation, Neoplastic
2
2006
273
0.130
Why?
Glioma
1
2014
138
0.130
Why?
Polypharmacy
1
2012
19
0.130
Why?
Program Development
2
2019
86
0.120
Why?
Hand Strength
1
2012
88
0.120
Why?
Osteoarthritis
1
2013
65
0.120
Why?
Anti-HIV Agents
1
2012
42
0.120
Why?
Cross-Sectional Studies
2
2015
1356
0.120
Why?
Gait
1
2012
92
0.120
Why?
Needs Assessment
1
2012
64
0.120
Why?
Influenza, Human
1
2013
119
0.120
Why?
Inflammation Mediators
1
2012
100
0.120
Why?
Bone Marrow Cells
2
2010
114
0.120
Why?
Muscle Fibers, Skeletal
1
2012
100
0.120
Why?
Shoulder Joint
1
2013
79
0.120
Why?
Exercise Test
1
2012
201
0.120
Why?
Disease Models, Animal
2
2014
1025
0.120
Why?
Survival Rate
2
2005
830
0.110
Why?
Membrane Proteins
1
2013
266
0.110
Why?
Blood Glucose
1
2014
499
0.110
Why?
Sensitivity and Specificity
1
2012
533
0.110
Why?
Postoperative Complications
1
2016
635
0.110
Why?
Promoter Regions, Genetic
2
2009
220
0.110
Why?
Toll-Like Receptor 8
1
2010
5
0.110
Why?
Receptors, Prostaglandin E
1
2010
4
0.110
Why?
Toll-Like Receptor 7
1
2010
11
0.110
Why?
CD4-Positive T-Lymphocytes
2
2013
49
0.110
Why?
Flow Cytometry
3
2005
172
0.110
Why?
Practice Guidelines as Topic
1
2014
374
0.110
Why?
Health Planning Guidelines
1
2010
7
0.110
Why?
Creatinine
1
2011
183
0.110
Why?
African Continental Ancestry Group
1
2012
409
0.110
Why?
Antigen-Presenting Cells
1
2010
6
0.110
Why?
Telomere
1
2010
11
0.110
Why?
Immunization Schedule
1
2010
23
0.110
Why?
Genetic Variation
1
2012
279
0.110
Why?
Toll-Like Receptor 4
1
2010
38
0.110
Why?
Syndrome
2
2013
68
0.110
Why?
Motor Activity
1
2013
331
0.110
Why?
Proto-Oncogene Proteins c-rel
1
2009
1
0.100
Why?
Transforming Growth Factor beta
1
2010
82
0.100
Why?
Nurses
1
2009
13
0.100
Why?
Chromatin
1
2009
17
0.100
Why?
Neoplasms
1
2016
645
0.100
Why?
Nursing Diagnosis
1
2009
2
0.100
Why?
Signal Transduction
2
2013
727
0.100
Why?
Triazenes
2
2006
4
0.100
Why?
Interleukin-6
1
2010
240
0.100
Why?
Body Temperature
1
2009
23
0.100
Why?
Diagnostic Tests, Routine
1
2009
21
0.100
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
158
0.100
Why?
Interdisciplinary Communication
1
2009
52
0.100
Why?
Disease Outbreaks
1
2009
35
0.100
Why?
Physical Examination
1
2009
74
0.100
Why?
Tissue Engineering
1
2015
614
0.100
Why?
Physician Assistants
1
2009
33
0.100
Why?
Metabolic Diseases
1
2008
20
0.100
Why?
Time Factors
3
2004
2077
0.100
Why?
Immunity
1
2008
21
0.100
Why?
HIV-1
1
2008
40
0.100
Why?
Analysis of Variance
2
2015
487
0.090
Why?
Antiretroviral Therapy, Highly Active
1
2008
40
0.090
Why?
Liver Diseases
1
2008
60
0.090
Why?
Aspergillosis
1
2007
4
0.090
Why?
Lymphocyte Depletion
1
2007
16
0.090
Why?
Opportunistic Infections
1
2007
10
0.090
Why?
Health Services for the Aged
1
2007
28
0.090
Why?
Th1 Cells
1
2007
17
0.090
Why?
Muscle, Skeletal
1
2012
483
0.090
Why?
Superoxide Dismutase
1
2007
48
0.090
Why?
Bone Marrow Transplantation
1
2007
77
0.090
Why?
Infusions, Intravenous
1
2007
89
0.090
Why?
Immunoglobulin G
1
2007
101
0.090
Why?
Education, Medical, Continuing
2
2006
54
0.080
Why?
Antigens, CD
2
2004
102
0.080
Why?
Renal Insufficiency, Chronic
1
2009
229
0.080
Why?
Liver
3
2015
465
0.080
Why?
Receptors, IgG
1
2005
7
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2005
20
0.080
Why?
Drug Resistance, Microbial
1
2005
9
0.080
Why?
Nitrobenzenes
1
2005
10
0.080
Why?
Receptors, Eicosanoid
1
2005
3
0.080
Why?
Program Evaluation
1
2006
177
0.080
Why?
Transcription, Genetic
2
2006
139
0.080
Why?
Immunologic Memory
1
2005
30
0.080
Why?
Risk Assessment
3
2012
1347
0.080
Why?
Chronology as Topic
1
2005
1
0.080
Why?
Emergency Medical Service Communication Systems
1
2005
2
0.080
Why?
Arachidonic Acids
1
2005
21
0.080
Why?
Colonic Neoplasms
1
2006
70
0.080
Why?
Emergency Medical Technicians
1
2005
11
0.080
Why?
Tennessee
1
2005
94
0.080
Why?
Organophosphorus Compounds
1
2005
43
0.080
Why?
Statistics as Topic
1
2005
106
0.080
Why?
Clinical Competence
2
2005
301
0.080
Why?
North Carolina
2
2016
1741
0.080
Why?
Sulfonamides
1
2005
72
0.080
Why?
Neutrophils
1
2005
103
0.080
Why?
Imidazoles
1
2005
117
0.070
Why?
Disease Susceptibility
2
2016
47
0.070
Why?
Research Design
2
2006
280
0.070
Why?
Nutrition Assessment
1
2005
66
0.070
Why?
Sex Distribution
1
2005
199
0.070
Why?
Cytomegalovirus
1
2004
13
0.070
Why?
Hematopoiesis
1
2004
32
0.070
Why?
Drug Therapy, Combination
1
2005
306
0.070
Why?
Phenotype
3
2013
656
0.070
Why?
Familial Mediterranean Fever
1
2003
2
0.070
Why?
Periodicity
1
2003
8
0.070
Why?
Models, Theoretical
1
2005
138
0.070
Why?
Genetic Heterogeneity
1
2003
14
0.070
Why?
Population Dynamics
1
2003
3
0.070
Why?
Receptors, Tumor Necrosis Factor
1
2003
43
0.070
Why?
Retirement
1
2003
11
0.070
Why?
Hematopoietic Stem Cells
1
2004
94
0.070
Why?
Biopsy
2
2015
243
0.070
Why?
Tocopherols
1
2002
4
0.070
Why?
Reproducibility of Results
1
2005
717
0.070
Why?
Case-Control Studies
1
2016
913
0.070
Why?
Training Support
1
2002
7
0.070
Why?
Response Elements
1
2002
14
0.070
Why?
Mortality
1
2004
109
0.070
Why?
Research Support as Topic
1
2002
30
0.060
Why?
Fluoroquinolones
1
2002
10
0.060
Why?
Fluorescent Antibody Technique
1
2002
83
0.060
Why?
Protein Transport
1
2002
78
0.060
Why?
Leukemia
1
2002
44
0.060
Why?
Cell Proliferation
1
2005
595
0.060
Why?
Lymphoma
1
2002
42
0.060
Why?
Demography
1
2002
116
0.060
Why?
Transplantation Conditioning
1
2002
14
0.060
Why?
Tumor Cells, Cultured
1
2002
162
0.060
Why?
Developing Countries
1
2002
38
0.060
Why?
Child
1
2008
2042
0.060
Why?
Health Status
1
2004
398
0.060
Why?
Chi-Square Distribution
2
2013
310
0.060
Why?
Residence Characteristics
1
2003
162
0.060
Why?
Cell Nucleus
1
2002
110
0.060
Why?
Glomerular Filtration Rate
2
2013
290
0.060
Why?
Albuminuria
2
2013
209
0.060
Why?
Data Collection
1
2002
171
0.060
Why?
Depression
1
2004
381
0.060
Why?
Educational Status
1
2002
171
0.060
Why?
Physicians
1
2003
141
0.060
Why?
Diagnosis, Differential
1
2002
508
0.050
Why?
Disease Progression
2
2015
588
0.050
Why?
Video Recording
1
2019
50
0.050
Why?
Respiration, Artificial
1
2019
89
0.050
Why?
Pedigree
2
2012
154
0.050
Why?
Genetic Predisposition to Disease
2
2013
965
0.050
Why?
Curriculum
1
2019
204
0.050
Why?
Host-Pathogen Interactions
1
2016
28
0.040
Why?
Caspase 3
2
2005
34
0.040
Why?
Caspases
2
2005
31
0.040
Why?
Liver Cirrhosis
1
2015
79
0.040
Why?
Reference Values
1
2015
241
0.040
Why?
Canada
1
2015
50
0.040
Why?
Tracheostomy
1
2015
26
0.040
Why?
Immunity, Mucosal
1
2014
6
0.040
Why?
Immunoglobulin A
1
2014
8
0.040
Why?
Administration, Topical
1
2015
131
0.040
Why?
Influenza A Virus, H3N2 Subtype
1
2014
22
0.040
Why?
Influenza B virus
1
2014
20
0.040
Why?
Orthomyxoviridae Infections
1
2014
19
0.040
Why?
Vaccines, Inactivated
1
2014
36
0.040
Why?
Viral Load
1
2014
54
0.040
Why?
Antibodies, Viral
1
2014
48
0.040
Why?
Immunity, Active
1
2013
1
0.040
Why?
Polysaccharides, Bacterial
1
2013
10
0.030
Why?
Transgenes
1
2013
45
0.030
Why?
Immunity, Humoral
1
2013
13
0.030
Why?
Immunomodulation
1
2013
27
0.030
Why?
Cystatin C
1
2013
27
0.030
Why?
Hepatitis B Antibodies
1
2013
1
0.030
Why?
Nonlinear Dynamics
1
2013
53
0.030
Why?
Regression Analysis
1
2014
307
0.030
Why?
DNA, Viral
1
2013
40
0.030
Why?
Liver Cirrhosis, Biliary
1
2013
5
0.030
Why?
Jaundice
1
2013
4
0.030
Why?
Interleukin-17
1
2013
15
0.030
Why?
Cholestasis
1
2013
19
0.030
Why?
Anti-Retroviral Agents
1
2013
18
0.030
Why?
Cell Line, Tumor
2
2005
698
0.030
Why?
Isotonic Contraction
1
2012
8
0.030
Why?
Gene Expression
2
2005
328
0.030
Why?
Myofibrils
1
2012
10
0.030
Why?
Secondary Prevention
1
2013
61
0.030
Why?
Disease Management
1
2014
128
0.030
Why?
Range of Motion, Articular
1
2013
112
0.030
Why?
Heredity
1
2012
14
0.030
Why?
Length of Stay
1
2014
288
0.030
Why?
Physical Conditioning, Animal
1
2012
36
0.030
Why?
Models, Animal
1
2013
168
0.030
Why?
Pilot Projects
1
2014
470
0.030
Why?
Muscular Atrophy
1
2012
65
0.030
Why?
Lung
1
2014
236
0.030
Why?
Monocytes
1
2013
112
0.030
Why?
Gene Frequency
1
2012
274
0.030
Why?
Myosin Heavy Chains
1
2012
99
0.030
Why?
Hospitalization
1
2014
364
0.030
Why?
Prevalence
1
2013
962
0.030
Why?
Quality of Life
1
2015
840
0.020
Why?
Prospective Studies
1
2014
2007
0.020
Why?
Graft vs Host Disease
1
2007
19
0.020
Why?
Cyclosporine
1
2007
35
0.020
Why?
Kidney
1
2012
473
0.020
Why?
Transplantation, Homologous
1
2007
122
0.020
Why?
Methotrexate
1
2007
63
0.020
Why?
Immunosuppression
1
2007
82
0.020
Why?
Tomography, X-Ray Computed
1
2013
931
0.020
Why?
Certification
1
2006
22
0.020
Why?
HCT116 Cells
1
2006
12
0.020
Why?
Proto-Oncogene Proteins c-jun
1
2006
6
0.020
Why?
Transcription Factor AP-1
1
2006
16
0.020
Why?
Survival Analysis
1
2007
471
0.020
Why?
Immunosuppressive Agents
1
2007
182
0.020
Why?
Coenzyme A Ligases
1
2005
2
0.020
Why?
Acyltransferases
1
2005
9
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2005
3
0.020
Why?
Hydroxyeicosatetraenoic Acids
1
2005
2
0.020
Why?
Pertussis Toxin
1
2005
15
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2005
11
0.020
Why?
Anilides
1
2005
11
0.020
Why?
Mitosis
1
2005
23
0.020
Why?
Drug Synergism
1
2005
67
0.020
Why?
Hela Cells
1
2005
76
0.020
Why?
Binding Sites
1
2005
122
0.020
Why?
Interviews as Topic
1
2006
321
0.020
Why?
Protein Binding
1
2005
195
0.020
Why?
Transfection
1
2005
182
0.020
Why?
Organizational Objectives
1
2004
26
0.020
Why?
ADP-ribosyl Cyclase
1
2004
4
0.020
Why?
Antigens, CD34
1
2004
51
0.020
Why?
Cell Line
1
2005
429
0.020
Why?
Virus Replication
1
2004
51
0.020
Why?
Founder Effect
1
2003
4
0.020
Why?
Polymerase Chain Reaction
1
2004
170
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2003
17
0.020
Why?
Kinetics
1
2004
192
0.020
Why?
Microsatellite Repeats
1
2003
26
0.020
Why?
Family Health
1
2003
92
0.020
Why?
Cohort Studies
1
2007
1721
0.020
Why?
Cell Culture Techniques
1
2004
163
0.020
Why?
Haplotypes
1
2003
261
0.020
Why?
Tissue Donors
1
2004
162
0.020
Why?
Probability
1
2002
159
0.020
Why?
Administration, Oral
1
2002
178
0.020
Why?
Drug Administration Schedule
1
2002
271
0.010
Why?
Dose-Response Relationship, Drug
1
2002
668
0.010
Why?
Follow-Up Studies
1
2002
2166
0.010
Why?
High's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (452)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_